Advanced search
Start date
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

How Natural Product Research has Contributed to Oral Care Product Development? A Critical View

Full text
Freires, Irlan Almeida [1] ; Rosalen, Pedro Luiz [1]
Total Authors: 2
[1] Univ Estadual Campinas, Piracicaba Dent Sch, Dept Physiol Sci, 901 Limeira Ave, BR-13414018 Piracicaba, SP - Brazil
Total Affiliations: 1
Document type: Journal article
Source: PHARMACEUTICAL RESEARCH; v. 33, n. 6, p. 1311-1317, JUN 2016.
Web of Science Citations: 10

Despite the high number of studies on the biological effects of natural products (NP) and molecules isolated therefrom, only a small part of them reach the clinical phase and become commercially available. In this perspective we make an analysis on how plant research has impacted oral health care over the last 15 years. Sixteen major clinical trial registry databases across the globe were searched for completed randomized clinical trials of herbal/natural product interventions (RCTHI) in theperiod 2000-2015. There was a considerable increase in the number of RCTHI, which points out an interest of academia and industry in the development of novel NP-based therapeutics. There is a trendfor greater heterogeneity of targeted dental conditions, mostly oral mucositis, periodontitis and dental caries. Topical application rather than systemic use predominated in the dental scope as mouthwashes, toothpastes, oral patches and gels have been the most commonly tested pharmaceutical forms. Today, despite the high number of in vitro, in vivo and clinical studies testing NP and/or NP-isolated molecules, only 11% (n = 9) of them are phase IV clinical trials assessing commercially available herbal products. This may be a result of poorly designed, superficial basic research that does not provide evidence to support the clinical testing of NP and derived molecules. As of now, plant research is promising although still accounts for a modest participation in the oral health care industry due to limited investment and incomplete or inconsistent information from preclinical and clinical testing. (AU)

FAPESP's process: 13/25080-7 - Prevalence of strains of Streptococcus mutans expressing Cnm in children and adults, and the role of this glycoprotein in the pathogen-host interactions
Grantee:Irlan de Almeida Freires
Support type: Scholarships in Brazil - Doctorate
FAPESP's process: 11/15984-0 - Anti-Candida, antiproliferative and cytotoxic activities evaluation of essential oil and fractions from Coriandrum sativum L.
Grantee:Irlan de Almeida Freires
Support type: Scholarships in Brazil - Master